PMID: 3037089Mar 1, 1987Paper

Arrhythmogenic and electrophysiological effects of alpha adrenoceptor stimulation during myocardial ischaemia and reperfusion

Journal of Molecular and Cellular Cardiology
W CullingD J Sheridan


To examine possible arrhythmogenic effects of alpha adrenoceptor stimulation, we studied the effects of methoxamine 10(-6) M on arrhythmias and cellular electrophysiology during global myocardial ischaemia and reperfusion in isolated Langendorff perfused guinea-pig hearts. To avoid interference from release of endogenous catecholamines during ischaemia or reperfusion, experiments were performed using catecholamine depleted hearts (myocardial noradrenaline = 11% of control). Catecholamine depletion markedly reduced the incidence of VT and VF during ischaemia and reperfusion and perfusion with methoxamine significantly reversed this. This arrhythmogenic effect of methoxamine was only observed during ischaemia or reperfusion, was independent of beta adrenoceptor blockade and H2 receptor blockade but was abolished by alpha adrenoceptor blockade with phentolamine. Catecholamine depletion blunted the ischaemia induced fall in action potential amplitude and Vmax and prolonged action potential duration and refractory period. Perfusion with methoxamine either partially or completely reversed these effects. Thus, alpha adrenoceptor stimulation has little effect on normally perfused myocardium, but may induce VT or VF during ischaemia or ...Continue Reading


Jan 1, 1993·Clinical Cardiology·A Om, M L Hess
Apr 1, 1993·Naunyn-Schmiedeberg's Archives of Pharmacology·S BarrettJ S Karliner
Nov 19, 1989·Molecular and Cellular Biochemistry·S K SrivastavaA Bhatnagar
Jun 7, 1995·Molecular and Cellular Biochemistry·M Yasutake, M Avkiran
Dec 3, 1990·Molecular and Cellular Biochemistry·T KawaiT Satake
Apr 25, 2012·Intensive Care Medicine·Christian A SchmittingerMartin W Dünser
May 19, 1989·European Journal of Pharmacology·M KoltaiP Braquet
Apr 20, 2001·Acta Anaesthesiologica Scandinavica·A MayrWalter R Hasibeder
Oct 6, 2009·Critical Care : the Official Journal of the Critical Care Forum·Christian TorgersenMartin W Dünser
Aug 26, 2009·Journal of Intensive Care Medicine·Martin W Dünser, Walter R Hasibeder
Jun 26, 2001·Journal of Autonomic Pharmacology·R G Chess-Williams, H L Milton
Mar 21, 2012·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Daniel Burkhoff, Srihari S Naidu
Sep 1, 1990·Circulation Research·A BhatnagarG Szabo
Mar 1, 1995·The Annals of Pharmacotherapy·J E TisdaleB J Zarowitz
Jun 27, 2020·European Journal of Pharmacology·Kamaldeep KaurRavi K Dhawan
Jan 1, 1994·Pharmacology & Therapeutics·R R Ruffolo, J P Hieble
Jan 1, 1990·Life Sciences·B G Benfey

Related Concepts

Related Feeds

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.


Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.


Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.